Haemonetics (NYSE:HAE) reported quarterly earnings results on February 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.31, beating the consensus estimate of $1.26 by $0.05 per share. Revenue came in at $339.0M, beating the estimate of $333.3M.
Haemonetics's stock moved following the earnings release. The stock currently trades at $59.34 with a market capitalization of $4.1B.